Objectives To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment
(FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) …

Objectives To analyze the oncologic outcomes of long-term fertility-sparing treatment (FST)
in patients with early-stage endometrial cancer (EC) and to determine the optimal duration of …

OBJECTIVE: To estimate the oncologic and pregnancy outcomes after oral progestin
treatment of women of reproductive age with stage IA endometrial adenocarcinoma with …

Objective Hormonal management is an alternative treatment for preserving fertility in
patients with presumed early stage endometrioid endometrial cancer. This study aimed to …

We thank the Editor-in-Chief of the Journal of Obstetrics and Gynaecology, ayman Ewies, for
the opportunity to discuss recent work dealing with a topic of great clinical interest that may …

Background The gold standard treatment for early-stage endometrial cancer (EC) is
hysterectomy with bilateral salpingo-oophorectomy (BSO) with lymphadenectomy. In …

Endometrial cancer (EC) in young women tends to be early-stage and low-grade; therefore,
such cases have good prognoses. Fertility-sparing treatment with progestin is a potential …

Simple Summary This article discusses a retrospective study describing sixteen years of
experience in the fertility-sparing treatment (FST) of endometrial cancer (EC) in a tertiary …

Objective To assess the outcomes of retreatment using progestin for recurrence after a
complete response with fertility-sparing treatment in patients with early endometrial cancer …

Objective The increasing use of fertility-preserving treatments in reproductive-aged patients
with early-stage endometrial cancer necessitates robust evidence on the effectiveness of …